March 29th 2023
The partnership will offer specialty physician practices across retina and other specialties access to SamaCare's platform.
Shared Perspectives in Managing Presbyopia – Understanding a New Paradigm for Optimizing Quality of Life
Perfecting Co-Management of Glaucoma – Utilizing Development in the Spectrum of Treatment Options
Expert Insights in Geographic Atrophy with Transformative Care on the Horizon – Understanding the Complement System as a Target for Treatment
(COPE Credit) Patient, Provider, and Caregiver Connection™: Individualizing Care in Allergic Conjunctivitis – Understanding the Patient’s Perspective in Alleviating Disease Burden
(CME Credit) Patient, Provider, and Caregiver Connection™: Individualizing Care in Allergic Conjunctivitis – Understanding the Patient’s Perspective in Alleviating Disease Burden
(COPE Credit) Expert Illustrations & Commentaries™: Envisioning New Therapies for Meibomian Gland Dysfunction-Associated DED
(COPE Credit) Community Practice Connections™: Expert Approaches in Cataract Surgery – Managing Advances in Techniques and Technologies With an Updated Armamentarium
(CME/CNE Credit) Expert Illustrations & Commentaries™: Envisioning New Therapies for Meibomian Gland Dysfunction-Associated DED
COPHy 2023: Weighing the merits of offering teprotumumab for all patients with thyroid eye diseaseMarch 25th 2023
Pedro Fonseca, MD, Coimbra Hospital and University Centre, Portugal, and Andrew G. Lee, MD, Blanton Eye Institute, Houston Methodist, Texas, USA, discuss the various pros and cons of offering teprotumumab for all patients with thyroid eye disease.
COPHy 2023: New restorative therapiesMarch 24th 2023
In a keynote lecture at the 14th Annual Congress on Controversies in Ophthalmology in Lisbon, Hendrik Scholl, MD, co-founder and director of the Institute of Molecular and Clinical Ophthalmology Basel, discussed its mission to unravel the mysteries of vision and human eye disease.
Report: Physician payments should be tied to inflation-based indexMarch 16th 2023
To support congressional action, 135 health organizations – including the American Academy of Ophthalmology – sent a letter to congressional leaders pointing out that a full inflation-based update is the primary solution to the ongoing problem with the Medicare Physician Fee Schedule.
Intergalactic Therapeutics announces positive preclinical results of Its non-viral gene therapy platform in ABCA4 retinopathiesMarch 15th 2023
The results support plan to advance lead program in ABCA4-related retinopathies into the clinic in 2024 and expansion into other ophthalmology indications.
UF Health researchers’ gene therapy for retina disorder shows promise in early testingMarch 14th 2023
According to a University of Florida Health, the researchers used gene therapy to both knock down and replace malfunctioning genetic material that affects light-sensing photoreceptors in the retina.
ONL Therapeutics gets funding to move lead compound into Phase 2 clinical trialMarch 13th 2023
According to the company, the funding supports the Phase 2 clinical study of ONL1204 ophthalmic solution to evaluate the safety and efficacy in patients diagnosed with macula-off rhegmatogenous retinal detachment.
Iveric Bio releases data in geographic atrophy from avacincaptad pegol GATHER trialsMarch 9th 2023
According to the company, post-hoc time-to-event analysis signals up to 59% risk reduction in rate of vision loss compared to sham treatment at 12 months. The analysis will be presented at the ARVO Annual Meeting from April 23-27 in New Orleans.
Anti-properdin antibody demonstrates efficacy in a primate model of wet-AMD and dry-AMDMarch 6th 2023
The company’s therapeutic is a single therapy for multiple forms of age-related macular degeneration. NM3086 is a highly potent alternative pathway (AP) blocker that does not affect the classical pathway.